Women in Ophthalmology - New York Chapter - 16th Annual Program

Wednesday, November 9, 2022, 6:00 PM - 9:00 PM, 3 West Club, 3 West 51st Street, New York, NY


This educational activity will focus on the Retina sub-specialty of ophthalmology specifically Wet Age Related Macular Degeneration (AMD) and Retinopathy of Prematurity (ROP) to provide women ophthalmologists, residents and fellows with the latest therapeutic insights, advances, current techniques, and approaches for managing these challenging conditions. This activity will also explore the various opportunities and resources available to those embarking on or progressing in a career in ophthalmology.

1. Describe the risk factors for and symptoms of Wet age-related macular degeneration (AMD)
2. Discuss the latest therapeutics used to treat and manage Wet age-related macular degeneration (AMD)
3. Discuss the risk factors for and causes of Retinopathy of Prematurity (ROP)
4. Discuss the latest therapeutic insights and advances in the medical and surgical management of Retinopathy of Prematurity (ROP)
5. Describe the evolution of screening and diagnostic advances in Retinopathy of Prematurity (ROP), including changes during the COVID-19 lockdown/pandemic
6. Recognize the variety of opportunities and resources available in a career journey in ophthalmology.

Registration Fee	$75.00

The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (1.25 hours), Non-Physician Attendance (1.25 hours)

3 West Club
3 West 51st Street
New York, NY 10019

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Mitigation of Relevant Financial Relationships

It is the policy of Icahn School of Medicine at Mount Sinai (ISMMS) to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-accredited educational activities. All faculty participating in the planning or implementation of an activity accredited by ISMMS are expected to disclose all of their financial relationships with ineligible companies existing within the prior 24 months. Relevant financial relationships will be mitigated and disclosed to learners before the activity takes place. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Wednesday, November 9, 2022